All Stories

  1. Galleria mellonella as an Invertebrate Model for Studying Fungal Infections

    Article • Journal of Fungi, February 2025, MDPI AG

    Carlos Pelleschi Taborda

  2. Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes

    Article • PLoS Neglected Tropical Diseases, October 2024, PLOS

    Carlos Pelleschi Taborda

  3. Saps1–3 Antigens in Candida albicans: Differential Modulation Following Exposure to Soluble Proteins, Mammalian Cells, and Infection in Mice

    Article • Infectious Disease Reports, June 2024, MDPI AG

    Carlos Pelleschi Taborda

  4. Proceedings of the second international meeting on endemic mycoses of the Americas (IMEMA) and first international symposium on implantation mycoses (ISIM)

    Article • Medical Mycology, May 2024, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  5. Towards a Better Understanding of Melanins from Dark Septate Endophytes (DSEs): Their Variability, Synthesis Pathways and Biological Roles

    Article • Journal of soil science and plant nutrition, March 2024, Springer Science + Business Media

    Carlos Pelleschi Taborda

  6. Human interleukin-36γ plays a crucial role in cytokine induction during Sporothrix brasiliensis and S. schenckii infection in keratinocytes and PBMCs

    Article • Microbial Pathogenesis, March 2024, Elsevier

    Carlos Pelleschi Taborda

  7. Use of 2D minilungs from human embryonic stem cells to study the interaction of Cryptococcus neoformans with the respiratory tract

    Article • Microbes and Infection, March 2024, Elsevier

    Carlos Pelleschi Taborda

  8. First occurrence of feline sporotrichosis in a metropolitan area of Central-West Brazil

    Article • Revista do Instituto de Medicina Tropical de São Paulo, January 2024, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  9. Skin innate immune response against fungal infections and the potential role of trained immunity

    Article • Mycoses, January 2024, Wiley

    Carlos Pelleschi Taborda

  10. Vaccine development for pathogenic fungi: current status and future directions

    Article • Expert Review of Vaccines, November 2023, Taylor & Francis

    Carlos Pelleschi Taborda

  11. Targeting the P10 Peptide in Maturing Dendritic Cells via the DEC205 Receptor In Vivo: A New Therapeutic Strategy against Paracoccidioidomycosis

    Article • Journal of Fungi, May 2023, MDPI AG

    Carlos Pelleschi Taborda

  12. The story of Paracoccidiodes gp43

    Article • Brazilian Journal of Microbiology, April 2023, Springer Science + Business Media

    Carlos Pelleschi Taborda

  13. Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis

    Article • Journal of Fungi, February 2023, MDPI AG

    Carlos Pelleschi Taborda

  14. Editorial: Tropical fungal diseases

    Article • Frontiers in Cellular and Infection Microbiology, December 2022, Frontiers

    Carlos Pelleschi Taborda

  15. Humicolopsis cephalosporioides synthesizes DHN-melanin in its chlamydospores

    Article • Mycological Progress, December 2022, Springer Science + Business Media

    Carlos Pelleschi Taborda

  16. In Vitro Antifungal Activity of LL-37 Analogue Peptides against Candida spp.

    Article • Journal of Fungi, November 2022, MDPI AG

    Carlos Pelleschi Taborda

  17. Hemorrhagic fever viruses: Pathogenesis, therapeutics, and emerging and re-emerging potential

    Article • Frontiers in Microbiology, October 2022, Frontiers

    Carlos Pelleschi Taborda

  18. Differential recognition and cytokine induction by the peptidorhamnomannan from Sporothrix brasiliensis and S. Schenckii

    Article • Cellular Immunology, August 2022, Elsevier

    Carlos Pelleschi Taborda

  19. Minilungs from Human Embryonic Stem Cells to Study the Interaction of Streptococcus pneumoniae with the Respiratory Tract

    Article • Microbiology Spectrum, June 2022, ASM Journals

    Carlos Pelleschi Taborda

  20. Minilungs from hESCs to study the interaction ofStreptococcus pneumoniaewith the respiratory tract

    Article • February 2022, Cold Spring Harbor Laboratory Press

    Carlos Pelleschi Taborda

  21. Differential recognition and cytokine induction by the peptidorhamnomannan from Sporothrix brasiliensis and S. schenckii

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Carlos Pelleschi Taborda

  22. Application of Nanoparticles to Invasive Fungal Infections

    Article • January 2022, Springer Science + Business Media

    Carlos Pelleschi Taborda

  23. Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis

    Article • Revista do Instituto de Medicina Tropical de São Paulo, January 2022, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  24. Immunoproteomic and Immunopeptidomic Analyses of Histoplasma capsulatum Reveal Promiscuous and Conserved Epitopes Among Fungi With Vaccine Potential

    Article • Frontiers in Immunology, November 2021, Frontiers

    Carlos Pelleschi Taborda

  25. Editorial: Pathogenesis of Dimorphic Fungal Infections

    Article • Frontiers in Cellular and Infection Microbiology, November 2021, Frontiers

    Carlos Pelleschi Taborda

  26. The influence of sample processing time on the performance ofMicrosporum caniscultures in cats

    Article • Veterinary Dermatology, November 2021, Wiley

    Carlos Pelleschi Taborda

  27. Antibody- Based Immunotherapy Combined With Antimycotic Drug TMP- SMX to Treat Infection With Paracoccidioides brasiliensis

    Article • Frontiers in Immunology, October 2021, Frontiers

    Carlos Pelleschi Taborda

  28. Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches

    Article • Journal of Fungi, May 2021, MDPI AG

    Carlos Pelleschi Taborda

  29. Neutrophil Cells Are Essential for The Efficacy of a Therapeutic Vaccine against Paracoccidioidomycosis

    Article • Journal of Fungi, May 2021, MDPI AG

    Carlos Pelleschi Taborda

  30. Identification of Potentially Therapeutic Immunogenic Peptides From Paracoccidioides lutzii Species

    Article • Frontiers in Immunology, May 2021, Frontiers

    Carlos Pelleschi Taborda

  31. Generation and Activity Evaluation of a Mouse-Human Immunoglobulin G1 Chimeric Antibody to Histoplasma capsulatum HSP60

    Article • April 2021, MDPI AG

    Carlos Pelleschi Taborda

  32. In Vitro and In Vivo Effect of Peptides Derived from 14-3-3 Paracoccidioides spp. Protein

    Article • Journal of Fungi, January 2021, MDPI AG

    Carlos Pelleschi Taborda

  33. Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis

    Article • Journal of Fungi, December 2020, MDPI AG

    Carlos Pelleschi Taborda

  34. Melanin as a Virulence Factor in Different Species of Genus Paracoccidioides

    Article • Journal of Fungi, November 2020, MDPI AG

    Carlos Pelleschi Taborda

  35. In vivo Activity of Silver Nanoparticles Against Pseudomonas aeruginosa Infection in Galleria mellonella

    Article • Frontiers in Microbiology, November 2020, Frontiers

    Carlos Pelleschi Taborda

  36. In Vitro and In Vivo Inhibitory Activity of Limonene against Different Isolates of Candida spp.

    Article • Journal of Fungi, September 2020, MDPI AG

    Carlos Pelleschi Taborda

  37. Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections

    Article • Frontiers in Cellular and Infection Microbiology, September 2020, Frontiers

    Carlos Pelleschi Taborda

  38. Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model

    Article • Journal of Fungi, September 2020, MDPI AG

    Carlos Pelleschi Taborda

  39. Advances in Fungal Peptide Vaccines

    Article • Journal of Fungi, July 2020, MDPI AG

    Carlos Pelleschi Taborda

  40. Pathogenicity Levels of Colombian Strains of Candida auris and Brazilian Strains of Candida haemulonii Species Complex in Both Murine and Galleria mellonella Experimental Models

    Article • Journal of Fungi, July 2020, MDPI AG

    Carlos Pelleschi Taborda

  41. Immunotherapy against Systemic Fungal Infections Based on Monoclonal Antibodies

    Article • Journal of Fungi, February 2020, MDPI AG

    Carlos Pelleschi Taborda

  42. A comment on “First report of tinea corporis caused by Arthroderma benhamiae in Brazil”

    Article • Brazilian Journal of Microbiology, January 2020, Springer Science + Business Media

    Carlos Pelleschi Taborda

  43. The secreted acid trehalase encoded by the CgATH1 gene is involved in Candida glabrata virulence

    Article • Memórias do Instituto Oswaldo Cruz, January 2020, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  44. Comparison of carpet and toothbrush techniques for the detection of Microsporum canis in cats

    Article • Journal of Feline Medicine and Surgery, October 2019, SAGE Publications

    Aline Santana, Carlos Pelleschi Taborda

  45. Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice

    Article • Frontiers in Microbiology, July 2019, Frontiers

    Carlos Pelleschi Taborda

  46. Unravelling the nature of the spongy dark material in aged Turkevich gold nanoparticles colloidal solutions by CytoViva® dark-field imaging and HRTEM analysis

    Article • Micron, June 2019, Elsevier

    Carlos Pelleschi Taborda

  47. Vaccine Development to Systemic Mycoses by Thermally Dimorphic Fungi

    Article • Current Tropical Medicine Reports, May 2019, Springer Science + Business Media

    Carlos Pelleschi Taborda

  48. Molecular detection of Histoplasma capsulatum indoors: A public health approach

    Article • Revista Iberoamericana de Micología, April 2019, Elsevier

    Carlos Pelleschi Taborda

  49. Glucosylceramides From Lomentospora prolificans Induce a Differential Production of Cytokines and Increases the Microbicidal Activity of Macrophages

    Article • Frontiers in Microbiology, March 2019, Frontiers

    Carlos Pelleschi Taborda

  50. Paracoccidioides spp. and Histoplasma capsulatum: Current and New Perspectives

    Article • Current Topics in Medicinal Chemistry, November 2018, Bentham Science Publishers

    Prof Luiz R Travassos, Carlos Pelleschi Taborda, Gil Benard

  51. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment

    Article • Journal of Ethnopharmacology, April 2018, Elsevier

    Carlos Pelleschi Taborda

  52. Esporotricose - gato como fonte de infecção em foco epidêmico familiar em Guarulhos, São Paulo: relato de caso

    Article • Brazilian Journal of Veterinary Research and Animal Science, December 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Carlos Pelleschi Taborda

  53. Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection

    Article • PLoS Neglected Tropical Diseases, September 2017, PLOS

    Carlos Pelleschi Taborda

  54. Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier

    Article • Frontiers in Microbiology, September 2017, Frontiers

    Carlos Pelleschi Taborda

  55. Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis

    Article • Frontiers in Microbiology, June 2017, Frontiers

    Carlos Pelleschi Taborda

  56. Antifungal Activity of the Biphosphinic Cyclopalladate C7a against Candida albicans Yeast Forms In Vitro and In Vivo

    Article • Frontiers in Microbiology, May 2017, Frontiers

    Cristina Spadari, Carlos Pelleschi Taborda

  57. Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation

    Article • International Journal of Antimicrobial Agents, April 2017, Elsevier

    Cristina Spadari, Carlos Pelleschi Taborda

  58. Development of enzyme immunoassays (ELISA and Western blot) for the serological diagnosis of dermatophytosis in symptomatic and asymptomatic cats

    Article • Medical Mycology, March 2017, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  59. Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates

    Article • Frontiers in Immunology, March 2017, Frontiers

    Carlos Pelleschi Taborda

  60. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    Carlos Pelleschi Taborda, Juliano Paccez

  61. Peptide Vaccine Against Paracoccidioidomycosis

    Article • January 2017, Springer Science + Business Media

    Carlos Pelleschi Taborda

  62. Celebration of 60th anniversary of Brazilian Society for Microbiology

    Article • Brazilian Journal of Microbiology, December 2016, Springer Science + Business Media

    Carlos Pelleschi Taborda

  63. Peptidorhamnomannan negatively modulates the immune response in a scedosporiosis murine model

    Article • Medical Mycology, June 2016, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  64. Identification and Analysis of the Role of Superoxide Dismutases Isoforms in the Pathogenesis of Paracoccidioides spp.

    Article • PLoS Neglected Tropical Diseases, March 2016, PLOS

    Carlos Pelleschi Taborda

  65. Antibodies Against Glycolipids Enhance Antifungal Activity of Macrophages and Reduce Fungal Burden After Infection with Paracoccidioides brasiliensis

    Article • Frontiers in Microbiology, February 2016, Frontiers

    Carlos Pelleschi Taborda

  66. Isolation of Dermatophytes from the Hair Coat of Healthy Persian Cats without Skin Lesions from Commercial Catteries Located in São Paulo Metropolitan Area, Brazil

    Article • Acta Scientiae Veterinariae, January 2016, Universidade Federal do Rio Grande do Sul

    Carlos Pelleschi Taborda

  67. SENSIBILIDADE DO LAMINOCULTIVO DERMATOBAC® PARA O DIAGNÓSTICO DA ENDOMETRITE FÚNGICA EM ÉGUAS

    Article • Ciência Animal Brasileira, December 2015, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  68. Macrophage Interaction with Paracoccidioides brasiliensis Yeast Cells Modulates Fungal Metabolism and Generates a Response to Oxidative Stress

    Article • PLOS One, September 2015, PLOS

    Carlos Pelleschi Taborda

  69. PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS

    Article • Revista do Instituto de Medicina Tropical de São Paulo, September 2015, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  70. Dendritic cell interactions withHistoplasmaandParacoccidioides

    Article • Virulence, May 2015, Taylor & Francis

    Carlos Pelleschi Taborda

  71. 2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents

    Article • Journal of Medicinal Chemistry, January 2015, American Chemical Society (ACS)

    Carlos Pelleschi Taborda

  72. Influence of melaleuca and copaiba oils onCandida albicansadhesion

    Article • Gerodontology, December 2014, Wiley

    Carlos Pelleschi Taborda

  73. Serological Diagnosis of Paracoccidioidomycosis: High Rate of Inter-laboratorial Variability among Medical Mycology Reference Centers

    Article • PLoS Neglected Tropical Diseases, September 2014, PLOS

    Carlos Pelleschi Taborda

  74. Monoclonal antibodies to heat shock protein 60 induce a protective immune response against experimental Paracoccidioides lutzii

    Article • Microbes and Infection, September 2014, Elsevier

    Carlos Pelleschi Taborda

  75. Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis

    Article • Mycopathologia, August 2014, Springer Science + Business Media

    Carlos Pelleschi Taborda

  76. Radiochemical pharmacokinetic profile of P10 peptide with antifungal properties

    Article • Medical Mycology, June 2014, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  77. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis

    Article • Fungal Genetics and Biology, November 2013, Elsevier

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  78. Erratum to: Isolation of Sporothrix schenckii From the Claws of Domestic Cats (Indoor and Outdoor) and in Captivity in São Paulo (Brazil)

    Article • Mycopathologia, August 2013, Springer Science + Business Media

    Carlos Pelleschi Taborda

  79. DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells

    Article • Microbes and Infection, March 2013, Elsevier

    Carlos Pelleschi Taborda

  80. Galleria mellonellaas a model host to studyParacoccidioides lutziiandHistoplasma capsulatum

    Article • Virulence, February 2013, Taylor & Francis

    Carlos Pelleschi Taborda

  81. Vaccines and immunotherapy against fungi: the new frontier

    Article • Frontiers in Microbiology, January 2013, Frontiers

    Carlos Pelleschi Taborda

  82. Paracoccidioidomycosis vaccine

    Article • Human Vaccines & Immunotherapeutics, October 2012, Taylor & Francis

    Carlos Pelleschi Taborda

  83. Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis

    Article • PLoS Neglected Tropical Diseases, February 2012, PLOS

    Carlos Pelleschi Taborda

  84. New advances in the development of a vaccine against paracoccidioidomycosis

    Article • Frontiers in Microbiology, January 2012, Frontiers

    Carlos Pelleschi Taborda

  85. The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide

    Article • Frontiers in Microbiology, January 2012, Frontiers

    Carlos Pelleschi Taborda

  86. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis

    Article • BMC Microbiology, January 2012, Springer Science + Business Media

    Carlos Pelleschi Taborda

  87. Prophylactic and Therapeutic Vaccination Using Dendritic Cells Primed with Peptide 10 Derived from the 43-Kilodalton Glycoprotein of Paracoccidioides brasiliensis

    Article • Clinical and Vaccine Immunology, November 2011, ASM Journals

    Carlos Pelleschi Taborda

  88. Isolation of Histoplasma capsulatum from bats in the urban area of São Paulo State, Brazil

    Article • Epidemiology and Infection, December 2010, Cambridge University Press

    Carlos Pelleschi Taborda

  89. Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 2010, Springer Science + Business Media

    Carlos Pelleschi Taborda

  90. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus

    Article • Journal of Feline Medicine and Surgery, April 2010, SAGE Publications

    Carlos Pelleschi Taborda

  91. Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis

    Article • Bone Marrow Transplantation, February 2010, Wiley

    Carlos Pelleschi Taborda

  92. Identification and characterization of antigenic proteins potentially expressed during the infectious process of Paracoccidioides brasiliensis

    Article • Microbes and Infection, September 2009, Elsevier

    Carlos Pelleschi Taborda

  93. Antifungal and antitumor models of bioactive protective peptides

    Article • Anais da Academia Brasileira de Ciências, September 2009, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  94. Resistance of melanized yeast cells of Paracoccidioides brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18

    Article • Memórias do Instituto Oswaldo Cruz, July 2009, FapUNIFESP (SciELO)

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  95. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006

    Article • Memórias do Instituto Oswaldo Cruz, May 2009, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  96. Paracoccidioides brasiliensis Vaccine Formulations Based on the gp43-Derived P10 Sequence and the Salmonella enterica FliC Flagellin

    Article • Infection and Immunity, February 2009, ASM Journals

    Carlos Pelleschi Taborda

  97. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis

    Article • Microbes and Infection, October 2008, Elsevier

    Carlos Pelleschi Taborda

  98. In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis

    Article • Antimicrobial Agents and Chemotherapy, September 2008, ASM Journals

    Carlos Pelleschi Taborda

  99. Glycoconjugates and polysaccharides of fungal cell wall and activation of immune system

    Article • Brazilian Journal of Microbiology, June 2008, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  100. The Monoclonal Antibody against the Major Diagnostic Antigen of Paracoccidioides brasiliensis Mediates Immune Protection in Infected BALB/c Mice Challenged Intratracheally with the Fungus

    Article • Infection and Immunity, May 2008, ASM Journals

    Carlos Pelleschi Taborda

  101. Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy

    Article • Mycopathologia, April 2008, Springer Science + Business Media

    Carlos Pelleschi Taborda

  102. Melanin as a virulence factor of Paracoccidioides brasiliensis and other dimorphic pathogenic fungi: a minireview

    Article • Mycopathologia, April 2008, Springer Science + Business Media

    Carlos Pelleschi Taborda

  103. Treatment options for paracoccidioidomycosis and new strategies investigated

    Article • Expert Review of Anti-infective Therapy, April 2008, Taylor & Francis

    Carlos Pelleschi Taborda

  104. Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound fromAllium sativum, associated with sulfamethoxazole/trimethoprim

    Article • Medical Mycology, January 2008, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  105. Peptide Immunization as an Adjuvant to Chemotherapy in Mice Challenged Intratracheally with Virulent Yeast Cells of Paracoccidioides brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, August 2006, ASM Journals

    Carlos Pelleschi Taborda

  106. Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility

    Article • Microbes and Infection, January 2006, Elsevier

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  107. Synthesis and Immunological Activity of a Branched Peptide Carrying the T-cell Epitope of gp43, the Major Exocellular Antigen of Paracoccidioides brasiliensis

    Article • Scandinavian Journal of Immunology, January 2004, Wiley

    Carlos Pelleschi Taborda

  108. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3-mediated interactions

    Article • European Journal of Immunology, July 2003, Wiley

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  109. More Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG

    Article • The Journal of Immunology, April 2003, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  110. Superoxide Dismutase Influences the Virulence of Cryptococcus neoformans by Affecting Growth within Macrophages

    Article • Infection and Immunity, January 2003, ASM Journals

    Carlos Pelleschi Taborda

  111. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved in Complement-Independent Antibody-Mediated Phagocytosis of Cryptococcus neoformans

    Article • Immunity, June 2002, Elsevier

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  112. Immunoglobulin G Monoclonal Antibodies to Cryptococcus neoformans Protect Mice Deficient in Complement Component C3

    Article • Infection and Immunity, May 2002, ASM Journals

    Carlos Pelleschi Taborda

  113. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection

    Article • Journal of Clinical Investigation, December 2001, American Society for Clinical Investigation

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  114. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection

    Article • Journal of Clinical Investigation, December 2001, American Society for Clinical Investigation

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  115. Immunoglobulin M Efficacy AgainstCryptococcus neoformans: Mechanism, Dose Dependence, and Prozone-Like Effects in Passive Protection Experiments

    Article • The Journal of Immunology, February 2001, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  116. PCR for Diagnosis of Paracoccidioidomycosis

    Article • Journal of Clinical Microbiology, January 2000, ASM Journals

    Carlos Pelleschi Taborda

  117. Evaluation of the INNO-LIA HTLV I/II Assay for Confirmation of Human T-Cell Leukemia Virus-Reactive Sera in Blood Bank Donations

    Article • Journal of Clinical Microbiology, May 1999, ASM Journals

    Carlos Pelleschi Taborda

  118. Mapping of the T-Cell Epitope in the Major 43-Kilodalton Glycoprotein ofParacoccidioides brasiliensisWhich Induces a Th-1 Response Protective against Fungal Infection in BALB/c Mice

    Article • Infection and Immunity, February 1998, ASM Journals

    Carlos Pelleschi Taborda

  119. Monoclonal antibody capture enzyme immunoassay for detection of Paracoccidioides brasiliensis antibodies in paracoccidioidomycosis

    Article • Journal of Clinical Microbiology, October 1994, ASM Journals

    Carlos Pelleschi Taborda

  120. Diagnosis of paracoccidioidomycosis by dot immunobinding assay for antibody detection using the purified and specific antigen gp43

    Article • Journal of Clinical Microbiology, February 1994, ASM Journals

    Carlos Pelleschi Taborda

  121. Antigenic relationship betweenParacoccidioides brasiliensisisolated from faeces of a penguin and a human isolate ofP. brasiliensis

    Article • Medical Mycology, January 1993, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  122. Diagnosis of paracoccidioidomycosis by passive haemagglutination assay of antibody using a purified and specific antigen-gp43

    Article • Medical Mycology, January 1993, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  123. The use of cell-free antigens ofParacoccidioides brasiliensisin serological tests

    Article • Medical Mycology, January 1991, Oxford University Press (OUP)

    Carlos Pelleschi Taborda